PN 76097
RN 00451 
AN 76259953
AU Govan-J-R.
TI Antibiotic therapy and cystic fibrosis: increased resistance of
   mucoid Pseudomonas aeruginosa to carbenicillin.
SO J-Antimicrob-Chemother. 1976 Jun. 2(2). P 215-7.
MJ ANTIBIOTICS: tu.  CARBENICILLIN: pd.  CYSTIC-FIBROSIS: dt.
   PSEUDOMONAS-AERUGINOSA: de.
MN CYSTIC-FIBROSIS: mi.  DRUG-RESISTANCE-MICROBIAL.  HUMAN.
EX The present communication reports the effect of the bacterial mucus
   on the activity of antibodies on strains of P. aeruginosa.  Mucoid
   variants of P. aeruginosa obtained from the non-mucoid strains PAO
   381 and PAT 404 by selection for phenotypic resistance to the
   virulent phage E 79 were more resistant to carbenicillin than the
   non-mucoid parent strains.  Mucoid P. aeruginosa strains isolated
   from two CF patients were more resistant to carbenicillin than
   non-mucoid strains isolated from the same samples of sputum.  When
   the experiments already described were repeated with oxytetracycline,
   in contrast to our experience with carbenicillin, mucoid strains were
   found to be more sensitive than non-mucoid strains.  To prove the
   hypothesis that mucoid strains can be selected in vivo by
   carbenicillin therapy it will be necessary to show that the level of
   carbenicillin in CF secretions is less than the minimum inhibitory
   concentrations of mucoid strains but greater than that of non-mucoid
   strains.  We are now investigating additional CF isolates in
   conjunction with the range of antibiotics used in chemotherapy of CF
   patients.
RF 001   BURNS MW              LANCET                           1   270 968
   002   DOGGETT RG            APPL MICROBIOL                  18   936 969
   003   DOGGETT RG            J PEDIATR                       68   215 966
   004   GOVAN JRW             J MED MICROBIOL                  8   513 975
   005   MARKS MI              J PEDIATR                       79   822 971
   006   WILLIAMS RJ           J MED MICROBIOL                  6   409 973
   007   ZIERDT CH             J BACTERIOL                     87  1003 964
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     2   BROWN MRW             J ANTIMICROB CHEMOTHER           3   198 977
     3   JONES SE              J PHARMACY PHARMACOL            29  P 69 977
     4   GOVAN JRW             J ANTIMICROB CHEMOTHER           4   233 978
     5   MARKOWITZ SM          INFECT IMMUN                    22   530 978
     6   HOLLOWAY BW           MICROBIOL REV                   43    73 979
     7   BRANSON D             AM J MED TECHNOLOGY             45   405 979
     8   GOVAN JRW             J GEN MICROBIOL                110   229 979
     9   SAVITSKAYA KI         ZH MIKROBIO EPIDEMIO IMMUNOBI 1979    96 979
    10   MARKOWITZ SM          J ANTIMICROB CHEMOTHER           6   251 980
    11   MARTIN AJ             ARCH DIS CHILD                  55   604 980
    12   CHOPRA I              ADV MICROB PHYSIOL              23   183 982
    13   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    33 982
    14   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    75 982
    15   OMBAKA EA             REV INFECT DIS                   5  S880 983
    16   HOOGKAMPKORSTANJE JAA J ANTIMICROB CHEMOTHER          12   175 983
    17   ANWAR H               FEMS MICROBIOL LETTERS          16   247 983
    18   TURNOWSKY F           FEMS MICROBIOL LETTERS          17   243 983
    19   ANWAR H               BIOCHIM BIOPHYS ACTA           761   119 983
    20   TANNENBAUM CS         ANTIMICROB AGENTS CHEMOTHER     25   673 984
    21   MODAI J               SEM HOP PARIS                   61  2325 985
    22   WOODS DE              J INFECT DIS                   151   581 985
    23   DERETIC V             J BACTERIOL                    165   510 986